|
Subscribe / Renew |
|
|
Contact Us |
|
| ► Subscribe to our Free Weekly Newsletter | |
| home | Welcome, sign in or click here to subscribe. | login |
| |
May 2, 2025
DexCare appointed Matthew Blosl as chief executive officer and board member. Blosl succeeds co-founder Derek Streat, who will transition to DexCare's Board of Directors. Additionally, DexCare co-founder Sean O'Connor has been named president. Blosl has more than two decades of leadership experience. Prior to joining DexCare, Blosl held a senior role at Experity, where he spearheaded commercial initiatives that expanded market presence and played a pivotal role in securing Experity's leadership position in the ambulatory electronic medical record market. Backed by leading institutional and strategic capital, DexCare partners with many of the nation's premier health systems, including Kaiser Permanente, Piedmont, Providence, Texas Health Resources, and Community Health Network. Under Blosl's leadership, DexCare will focus on accelerating platform innovation, including the introduction of AI-driven capabilities, and deepening market adoption. Health systems rely on DexCare's platform to achieve the operational clarity to best-utilize clinician hours, to intelligently navigate consumers to care, and to regain cost controls for sustainable growth. DexCare is headquartered in Seattle and serves more than 57 million patients across 50 states.